Integrated BioTherapeutics' Grant

Integrated BioTherapeutics raised a round of funding on August 02, 2017. Investors include National Institute of Allergy and Infectious Diseases.

Integrated BioTherapeutics is a biotechnology company focusing on the discovery of novel vaccines and therapies for emerging infectious diseases with a pipeline that includes promising product candida…

Articles about Integrated BioTherapeutics' Grant: